J&J to buy Momenta in $6.5 bn deal
The acquisition will bolster J&J’s portfolio of drugs for autoimmune diseases
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib
The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…
Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR
Normally the final trial takes about six to nine months
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)
NPPA rejects IPA request for upward price revision of five per cent on all drugs
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19…
How robots are lending a hand with healthcare, medical devices and pharma worldwide
From pharma and medical device production to medical and research laboratories, the latest robotics solutions can support the…
AstraZeneca gets DCGI nod to import and market Olaparib film coated tablets
It is additionally indicated as a monotherapy to treat adults with metastatic castration-resistant prostate cancer and homologous…
HEAL Health Connect Solutions to host e-Summit on Emerging Dimensions in Pharma Excellence
Held in collaboration with Express Pharma, the virtual event will be held on August 20, followed by Pharma Excellence Awards
ZIM Labs in exclusive licensing agreement with Hypera Pharma for Vitamin D3 orally dispersible films
The product is intended for bone health in infants and the elderly
Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India
Dr Reddy’s AVIGAN comes in a pack of 122 tablets with a two-year shelf life